Steroids, Chronic Lung Disease, and Retinopathy of Prematurity
1 Division of Perinatal Medicine, Dept of Pediatrics, Yale University School of Medicine, New Haven, CT
This issue of Pediatrics contains two conflicting, retrospective observational studies concerning the relation between steroid therapy for chronic lung disease (CLD) and the need for cryotherapy for severe retinopathy of prematurity (ROP). Batton et al1 noted that more infants treated with dexamethasone for CLD needed cryotherapy for ROP, whereas Sobel and Philip2 found that steroid therapy for CLD did not affect the number of infants who needed cryotherapy for ROP. In fact, Sobel and Philip suggest that prolonged (>24 days) treatment with steroids may actually reduce the likelihood that ROP will reach "threshold" criteria for cryotherapy. Are these reports really contradictory?
This article has been cited by other articles:
![]() |
The Vermont Oxford Network Steroid Study Group Early Postnatal Dexamethasone Therapy for the Prevention of Chronic Lung Disease Pediatrics, September 1, 2001; 108(3): 741 - 748. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Yossuck, Y. Yan, M. Tadesse, and R. D. Higgins Dexamethasone and Critical Effect of Timing on Retinopathy Invest. Ophthalmol. Vis. Sci., September 1, 2000; 41(10): 3095 - 3099. [Abstract] [Full Text] |
||||
![]() |
T. Bhuta and A. Ohlsson Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease Arch. Dis. Child. Fetal Neonatal Ed., July 1, 1998; 79(1): 26F - 33. [Abstract] [Full Text] |
||||







